Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CTLA4 Antikörper

Dieses Anti-CTLA4-Antikörper ist ein Kaninchen Chimeric-Antikörper zur Detektion von CTLA4 in IF und BR. Geeignet für Maus.
Produktnummer ABIN7072467

Kurzübersicht für Rekombinanter CTLA4 Antikörper (ABIN7072467)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 153
  • 83
  • 45
  • 14
  • 3
Maus

Wirt

  • 91
  • 79
  • 22
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 130
  • 72
  • 2
Chimeric

Konjugat

  • 108
  • 18
  • 13
  • 11
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 97
  • 91
  • 63
  • 59
  • 45
  • 36
  • 18
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunofluorescence (IF), Blocking Reagent (BR)

Klon

9D9
  • Verwendungszweck

    Anti-CTLA-4 [9D9], Rabbit IgG, kappa

    Spezifität

    The antibody is specific for CTLA-4.

    Produktmerkmale

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Aufreinigung

    Protein A affinity purified

    Immunogen

    The antibody was raised against CTLA-4.

    Isotyp

    IgG kappa
  • Applikationshinweise

    The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non-irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs.

    Kommentare

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA-4

    Hintergrund

    CD152, CTLA4, Cytotoxic T-Lymphocyte Associated Protein 4, Insulin-Dependent Diabetes Mellitus 12, Celiac Disease 3, Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Fo

    UniProt

    P09793

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!